Breaking News Instant updates and real-time market news.

LRCX

Lam Research

$96.17

1.34 (1.41%)

, KLAC

KLA-Tencor

$71.21

0.91 (1.29%)

06:47
10/06/16
10/06
06:47
10/06/16
06:47

Lam Research to host conference call

Conference call to discuss termination of proposed combination with KLA-Tencor will be held on October 6 at 9 am. Webcast Link

LRCX

Lam Research

$96.17

1.34 (1.41%)

KLAC

KLA-Tencor

$71.21

0.91 (1.29%)

  • 06

    Oct

  • 19

    Oct

  • 18

    Nov

LRCX Lam Research
$96.17

1.34 (1.41%)

08/29/16
08/29/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. T-Mobile (TMUS) upgraded to Outperform from Market Perform at Wells Fargo, with analyst Jennifer Fritzsche saying the company's free cash flow should ramp significantly in 2017. T-Mobile should also see continued positive momentum in subscriber growth and be helped by M&A speculation post the Presidential election, said Fritzsche, who raised her price target range for the shares to $52-$54 from $48-$50. 2. KLA-Tencor (KLAC) upgraded to Outperform from Market Perform at Cowen by analyst Timothy Arcuri, who views the shares as "too interesting to ignore" regardless of the Lam Research (LRCX) deal outcome. KLA's risk/reward, even if the deal breaks, is now 3:1 to the upside, which is hard to find in semis, Arcuri tells investors in a research note. 3. Allegheny Technologies (ATI) upgraded to Buy from Hold at Deutsche Bank, with Deutsche Bank analyst Jorge Beristain saying leverage concerns have eased following the closure of the company's Rowley facility. Management is acting to exit low-margin stainless products, said Beristain. 4. CBL & Associates (CBL) upgraded to Buy from Hold at Jefferies, as analyst Omotayo Okusanya thinks "several issues" that have been an overhang on the shares are now resolved or are in the process of resolution. The company's portfolio quality is rising while its balance sheet is in better shape, Okusanya tells investors. 5. AstraZeneca upgraded to Buy from Hold at Argus. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/08/16
SBSH
09/08/16
NO CHANGE
Target $102
SBSH
Buy
Citi stil sees risk in Lam, KLA-Tencor merger deal
Dealreporter yesterday published an article yesterday stating that Lam Research (LRCX) is in discussions with China's MOFCOM to resolve deal concerns, Citi analyst Atif Malik tells investors in a research note. The analyst continues to see risk in Lam, KLA-Tencor (KLAC) deal on decreased competition concerns with regulators. He adds that equipment peers at the Citi Technology conference this week spoke of concentration concerns with the deal. Malik has a Buy rating on Lam with a $102 price target.
10/05/16
RBCM
10/05/16
NO CHANGE
RBCM
Micron report reads positively for Applied Materials, Lam, says RBC Capital
Following Micron's (MU) quarterly report and guidance, RBC Capital Amit Daryanani said he sees positive read-through from the report for Applied Materials (AMAT), Lam Research (LRCX), ASML (ASML), Western Digital (WDC) and Intel (INTC). Micron management expects capex spending of $4.8B-$5.2B for FY17, noted Daryanani, who believes continued 3D NAND spending will benefit Applied and Lam the most.
10/06/16
RILY
10/06/16
UPGRADE
Target $86
RILY
Buy
KLA-Tencor upgraded to Buy from Neutral at B. Riley
B. Riley analyst Craig Ellis upgraded KLA-Tencor (KLAC) to Buy and raised his price target for the shares to $86 from $78 after the company discontinued its proposed merger with Lam Research (LRCX).
KLAC KLA-Tencor
$71.21

0.91 (1.29%)

09/13/16
FBCO
09/13/16
UPGRADE
Target $85
FBCO
Outperform
KLA-Tencor upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst Farham Ahmad upgraded KLA-Tencor (KLAC) to Outperform and raised its price target to $85 from $82. Ahmad does not expect the Lam Research (LRCX) merger to go through but views KLA-Tencor as attractive on a standalone valuations. The analyst's FY17 earnings estimate of $5.34 is 11% above the Street, and he sees potential for multiple expansion driven by OpM and 3% dividend yield.
10/03/16
FBCO
10/03/16
NO CHANGE
Target $85
FBCO
Outperform
KLA-Tencor added to US Focus List at Credit Suisse
Credit Suisse analyst Farhan Ahmad added KLA-Tencor to the US Focus List and reiterated his views that shares are very attractive in near term given upside his estimates, 2H 2016/CY17 earnings are 10%/7% above Street. The analyst has greater conviction that stock is already pricing in the breakup of the proposed Lam Research (LRCX) merger following meetings and calls with investors over the last few weeks, and sees significant interest in KLA-Tencor shares from investors. Ahmad commented on investor concerns and thinks Gen 5 will take share from Ebeam inspection, Foundry 28nm capex from China could be a 2018 growth driver, and believes valuation reflects the merger and sees upside expansion to the multiple. Ahmad rates KLA-Tencor an Outperform with an $85 price target.

TODAY'S FREE FLY STORIES

MEI

Methode Electronics

$40.10

1.45 (3.75%)

07:54
06/23/17
06/23
07:54
06/23/17
07:54
Recommendations
Methode Electronics analyst commentary  »

Baird remains a buyer of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HNHPF

Hon Hai Precision

, TOSYY

Toshiba, also use TOSBF

$17.39

0.085 (0.49%)

07:53
06/23/17
06/23
07:53
06/23/17
07:53
Periodicals
Foxconn's Gou still sees 50% chance of landing Toshiba chip unit, DigiTimes says »

Foxconn (HNHPF) Chairman…

HNHPF

Hon Hai Precision

TOSYY

Toshiba, also use TOSBF

$17.39

0.085 (0.49%)

TOSBF

Toshiba, also use TOSYY

$2.88

-0.01 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$35.36

0.48 (1.38%)

07:53
06/23/17
06/23
07:53
06/23/17
07:53
Hot Stocks
AstraZeneca announces positive CHMP opinion for Faslodex »

AstraZeneca announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

V

Visa

$93.95

-0.59 (-0.62%)

07:52
06/23/17
06/23
07:52
06/23/17
07:52
Recommendations
Visa analyst commentary  »

Visa a good idea for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CARA

Cara Therapeutics

$19.88

0.38 (1.95%)

07:51
06/23/17
06/23
07:51
06/23/17
07:51
Technical Analysis
Technical View: Cara Therapeutics at new 52-week high in pre-market »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jul

KMX

CarMax

$62.50

2.76 (4.62%)

07:51
06/23/17
06/23
07:51
06/23/17
07:51
Recommendations
CarMax analyst commentary  »

CarMax weakness on sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 29

    Jun

  • 30

    Jun

07:50
06/23/17
06/23
07:50
06/23/17
07:50
General news
Treasury Market Outlook: bonds are mixed while stocks are mostly lower »

Treasury Market Outlook:…

ENTA

Enanta

$37.11

1.77 (5.01%)

, ABBV

AbbVie

$73.18

1.84 (2.58%)

07:49
06/23/17
06/23
07:49
06/23/17
07:49
Hot Stocks
Enanta announces AbbVie recieves CHMP positive opinion for MAVIRET »

Enanta Pharmaceuticals…

ENTA

Enanta

$37.11

1.77 (5.01%)

ABBV

AbbVie

$73.18

1.84 (2.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OTIC

Otonomy

$17.75

0.25 (1.43%)

07:48
06/23/17
06/23
07:48
06/23/17
07:48
Recommendations
Otonomy analyst commentary  »

Otonomy trial has high…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOG

Harley-Davidson

$56.23

0.27 (0.48%)

07:45
06/23/17
06/23
07:45
06/23/17
07:45
Recommendations
Harley-Davidson analyst commentary  »

Harley-Davidson retail…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 02

    Oct

HAIN

Hain Celestial

$32.66

-0.5 (-1.51%)

, AMZN

Amazon.com

$1,001.30

-0.93 (-0.09%)

07:44
06/23/17
06/23
07:44
06/23/17
07:44
Recommendations
Hain Celestial, Amazon.com, Whole Foods analyst commentary  »

Hain Celestial guidance…

HAIN

Hain Celestial

$32.66

-0.5 (-1.51%)

AMZN

Amazon.com

$1,001.30

-0.93 (-0.09%)

WFM

Whole Foods

$43.20

-0.06 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

GLNG

Golar LNG

$21.70

-0.06 (-0.28%)

07:43
06/23/17
06/23
07:43
06/23/17
07:43
Recommendations
Golar LNG analyst commentary  »

Golar LNG upcoming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENOC

EnerNOC

$7.65

2.25 (41.67%)

07:43
06/23/17
06/23
07:43
06/23/17
07:43
Downgrade
EnerNOC rating change  »

EnerNOC downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEJU

Leju

$2.46

0.07 (2.93%)

07:41
06/23/17
06/23
07:41
06/23/17
07:41
Downgrade
Leju rating change  »

Leju downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,001.30

-0.93 (-0.09%)

07:41
06/23/17
06/23
07:41
06/23/17
07:41
Periodicals
Amazon files patent application for multi-level drone tower, BI reports »

Amazon is seeking to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

HAIN

Hain Celestial

$32.66

-0.5 (-1.51%)

07:38
06/23/17
06/23
07:38
06/23/17
07:38
Recommendations
Hain Celestial analyst commentary  »

Hain Celestial guidance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

GILD

Gilead

$70.48

2.98 (4.41%)

07:38
06/23/17
06/23
07:38
06/23/17
07:38
Hot Stocks
European CHMP adopts positive opinion for Gilead's Vosevi »

Gilead Sciences announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jul

GILD

Gilead

$70.48

2.98 (4.41%)

07:37
06/23/17
06/23
07:37
06/23/17
07:37
Initiation
Gilead initiated  »

Gilead initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jul

AKS

AK Steel

$6.30

0.11 (1.78%)

07:37
06/23/17
06/23
07:37
06/23/17
07:37
Technical Analysis
Technical View: AK Steel rises in pre-market, analyst action »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

OCUL

Ocular Therapeutix

$11.54

0.5 (4.53%)

07:36
06/23/17
06/23
07:36
06/23/17
07:36
Downgrade
Ocular Therapeutix rating change  »

Ocular Therapeutix…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

QUIK

QuickLogic

07:35
06/23/17
06/23
07:35
06/23/17
07:35
Hot Stocks
QuickLogic collaborates with AISpeech »

QuickLogic announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

BAC

Bank of America

$22.93

-0.2 (-0.86%)

, GE

General Electric

$27.55

-0.23 (-0.83%)

07:35
06/23/17
06/23
07:35
06/23/17
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

BAC

Bank of America

$22.93

-0.2 (-0.86%)

GE

General Electric

$27.55

-0.23 (-0.83%)

SNAP

Snap

$17.64

0.37 (2.14%)

AKS

AK Steel

$6.30

0.11 (1.78%)

WLL

Whiting Petroleum

$5.14

-0.03 (-0.58%)

BX

Blackstone

$33.06

0.1 (0.30%)

FSLR

First Solar

$38.42

1.19 (3.20%)

TECK

Teck Resources

$15.88

0.58 (3.79%)

CSIQ

Canadian Solar

$15.07

1.08 (7.72%)

HZNP

Horizon Pharma

$11.87

0.44 (3.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

  • 19

    Jul

  • 25

    Jul

  • 02

    Oct

BBRY

BlackBerry

$11.06

0.41 (3.85%)

07:34
06/23/17
06/23
07:34
06/23/17
07:34
Technical Analysis
Technical View: BlackBerry falls after Q1 revenue misses consensus »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

ESPR

Esperion

$42.31

1.29 (3.14%)

07:33
06/23/17
06/23
07:33
06/23/17
07:33
Initiation
Esperion initiated  »

Esperion initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSNLF

Samsung

, BIIB

Biogen

$280.57

1.97 (0.71%)

07:33
06/23/17
06/23
07:33
06/23/17
07:33
Hot Stocks
Samsung Bioepis' Imrali recommended for approval by EMA »

Samsung Bioepis announced…

SSNLF

Samsung

BIIB

Biogen

$280.57

1.97 (0.71%)

ABBV

AbbVie

$73.18

1.84 (2.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.